Eli Lilly Stocks Rise 7% With Raised Guidance and $900 Million in Quarterly Benefits

Eli Lilly NYSE:LLY raised its annual outlook, but the revenue mix deserves a closer look. Shares were shown at $1,379 at 10.40am EST on October 29, up approximately 7.04% from the previous close; the image does not specify an ET timestamp. The earnings report puts demand for Mounjaro and Zepbound i…